DLX2 and gastric cancer: The results revealed that after 72 hours of DLX2 overexpression, the number of AGS and HGC-27 cells in the experimental group was significantly greater than that in the control group (pcDNA3.1(+)) (Figure 4D), indicating a protumorigenic role of DLX2 in gastric cancer.